Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of LifeStance Health Group, Inc. (LFST) Investigation

Published October 6, 2023

NEW YORK, NY / ACCESSWIRE / October 6, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST). Investors who purchased LifeStance securitiesprior to June 10, 2021, and continue to holdto the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site:

The investigation concerns whether LifeStance and certain of its officers and/or directors have allegedly engaged in corporate wrongdoing.

If you are aware of any facts relating to this investigation or purchased LifeStance shares, you can assist with this investigation by visiting the firm's site: You can also contact Peretz Bronstein or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 |

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View source version on


News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.